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Abstract
The present study focused on the evaluation of the effects of
operant behavioural (OBT) and cognitive behavioural (CBT)
treatments for fibromyalgia syndrome (FMS). One hundred and
twenty-five patients who fulfilled the American College of
Rheumatology criteria for FMS were randomly assigned to OBT
(n = 43), CBT (n = 42), or an attention-placebo (AP) treatment
(n = 40) that consisted of discussions of FMS-related problems.
Assessments of physical functioning, pain, affective distress,
and cognitive and behavioural variables were performed pre-
treatment and post-treatment as well as 6 and 12 months post-
treatment. Patients receiving the OBT or CBT reported a
significant reduction in pain intensity post-treatment (all Fs >
3.89, all Ps < 0.01). In addition, the CBT group reported
statistically significant improvements in cognitive (all Fs > 7.95,
all P < 0.01) and affective variables (all Fs > 2.99, all Ps < 0.02),
and the OBT group demonstrated statistically significant
improvements in physical functioning and behavioural variables
(all Fs > 5.99, all Ps < 0.001) compared with AP. The AP group
reported no significant improvement but actually deterioration in
the outcome variables. The post-treatment effects for the OBT
and CBT groups were maintained at both the 6- and 12-month
follow-ups. These results suggest that both OBT and CBT are
effective in treating patients with FMS with some differences in
the outcome measures specifically targeted by the individual
treatments compared with an unstructured discussion group.
The AP group showed that unstructured discussion of FMS-
related problems may be detrimental.
Introduction
Fibromyalgia syndrome (FMS) is defined by the presence of
widespread pain of at least 3 months' duration and pain upon
palpation of at least 11 out of 18 specific tender points (TPs).
Patients diagnosed with FMS also report disordered sleep,
excessive fatigue, and a range of physical [1,2], cognitive
[3,4], affective [5,6], stress-related [7,8], and behavioural
symptoms [9,10]. The cause of FMS is not known; however,
several mechanisms may be involved [11-13].
Two psychologically based treatment approaches, cognitive
behaviour therapy (CBT) and operant behaviour therapy
(OBT), have been reported to provide benefits for a significant
proportion of patients with FMS [14-16]. A meta-analysis [17]
of 49 treatment outcome studies compared the efficacy of
pharmacological and non-pharmacological treatments. CBT
yielded significantly greater improvements in physical status,
symptoms, psychological functioning, and functional ability
compared with physical therapy and was more effective for
FMS symptoms and daily functioning than was pharmacologi-
cal treatment with antidepressants [17]. These results and a
recent evidence-based clinical practice guideline [18] sug-
gest that optimal treatment of FMS should include physical
exercise, antidepressant medication, and cognitive behav-
ioural methods.
Treatment based on operant conditioning [19] has been
applied to a variety of chronic pain syndromes. OBT empha-
sises increased activity, inclusion of significant others to
reduce reinforcement of pain behaviours, and the reduction of
pain-contingent medication [19,20]. Only a few studies have
reported on the effectiveness of OBT with patients with FMS
ANOVA = analysis of variance; AP = attention-placebo; CBT = cognitive behavioural therapy; ES = effect size; FIQ = Fibromyalgia Impact Question-
naire; FMS = fibromyalgia syndrome; MANOVA = multivariate analysis of variance; MPI = West Haven-Yale Multidimensional Pain Inventory; OBT = 
operant behavioral therapy; PRSS = Pain-Related Self-Statements Scale; TBS = Tübingen Pain Behaviour Scale; TP = tender point.Arthritis Research & Therapy    Vol 8 No 4    Thieme et al.
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[14,21]. For example, OBT was shown to produce a signifi-
cant and stable reduction in pain intensity, interference, solici-
tous behaviour of the spouse, medication, pain behaviours,
number of physician visits and days at a hospital, and improve-
ment in sleeping. Sixty-five percent of the OBT-treated
patients showed clinically significant improvement when com-
pared with patients who received physical therapy alone [21].
Although OBT and CBT share some common elements, they
make different assumptions and have different emphases.
OBT focuses on the modification of reinforcement contingen-
cies that maintain pain behaviours and on changing pain-
related behaviours, whereas CBT emphasises the role of mala-
daptive beliefs and expectations of patients (that is, cognitive
variables in the maintenance and exacerbation of symptoms
and disability) and thus aims primarily to alter the attitude of
the patients toward the pain and self-management.
Turk and colleagues have demonstrated that patients diag-
nosed with FMS are heterogeneous [13], characterised by
several patterns based on how they respond to their symp-
toms. They suggested that different treatments that are
matched to specific psychosocial and behavioural features
may be required. The aims of the present study were (a) to
examine the effectiveness of CBT and OBT in comparison
with an attention-placebo (AP) group and (b) to compare the
relative effectiveness of OBT and CBT with each other.
Specific hypotheses
1. CBT and OBT will produce significant improvements in
pain, physical functioning, and emotional distress in patients
with FMS.
2. CBT and OBT will produce significantly greater improve-
ments in pain, physical functioning, and emotional distress
than the AP treatment.
3. CBT will produce significantly greater effects than the OBT
and AP groups on coping and catastrophising responses.
4. OBT will produce significantly greater reductions in pain
behaviours, physical disability, and physician visits than the
CBT or AP treatments.
Materials and methods
Participants
A sample of 125 consecutive married female patients with
FMS was recruited from 10 outpatient rheumatological clinics.
The groups were comparable with respect to demographic
and FMS-specific variables (for example, number of TPs and
severity of TP pain [22]; Table 1).
Study protocol
All patients signed informed consent and were randomly
assigned to OBT, CBT, or AP treatment. The study was
Table 1
Demographic and clinical data of the patients (n = 125)
OBT (n = 43) CBT (n = 42) AP (n = 40)
Mean SD 
(Range)
Mean SD 
(Range)
Mean SD 
(Range)
Age (in years) 43.23 49.13 47.46
9.03 10.03 9.75
(21–59) (22–66) (21–67)
Duration of pain (in years) 8.98 9.08 8.73
10.11 8.50 8.77
(1.5–43) (0.5–36) (0.5–43)
Number of painful regions 7.41 6.74 7.06
1.81 2.18 2.07
(4–10) (3 – 10) (3–10)
Number of tender points 16.66 17.25 16.88
3.93 4.47 4.33
(11–18) (11–18) (11–18)
Mean tender point pain 
intensity
5.73 4.59 4.21
2.14 1.49 1.73
(1.7–8.3) (1.9–7.3) (0–10)
Number of physician visits 36.87 30.55 34.25
15.15 16.20 16.33
(18–69) (4–86) (14–84)
Drug (n/day of amytriptiline 
25 mg)
3.62 3.16 3.36
2.16 3.62 2.78
(0–9) (0–16) (0–12)
Treatment expectation 4.33 4.30 4.06
1.17 1.07 0.99
(2–6) (2–6) (2–6)
Treatment satisfaction (first 
session)
4.39 4.30 3.94
0.99 0.81 0.87
(3–6) (3–5) (3–5)
n (%) n (%) n (%)
Occupational status
Working 17 (39.5) 19 (45.2) 20 (50.0)
Unemployed 16 (37.2) 16 (38.1) 12 (30.0)
Workers' compensation 3 (7.0) 2 (4.8) 3 (7.5)
Retired 7 (16.3) 4 (9.5) 3 (7.5)
Student 0 (0.0) 1 (2.4) 2 (5.0)
AP, attention-placebo; CBT, cognitive behavior therapy; OBT, operant 
behaviour therapy; SD, standard deviation.Available online http://arthritis-research.com/content/8/4/R121
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approved by the local ethics committee. The administering of
the three types of treatment was counterbalanced in order to
control for time of year and time of entry into the clinical trial.
Figure 1 provides an overview of the patient flow in the study
based on the CONSORT guidelines [23].
All patients received a general medical and a rheumatological
assessment (see below). The inclusion criteria consisted of (a)
meeting ACR (American College of Rheumatology) criteria of
FMS [1], (b) pain for a period of at least 6 months, (c) married,
(d) willingness of the spouse to participate, and (e) ability to
complete the questionnaires and understand the treatment
components. The exclusion criteria consisted of inflammatory
rheumatologic diseases and any concurrent major disease
such as cancer, diabetes, or kidney failure.
Assessments
Physical assessment
The physical assessment included blood chemistry analysis,
neurological examination, and evaluation of TPs. The number
of positive TPs and pain intensity of TPs, rated on a numeric
scale from 0 (no pain) to 10 (worst pain possible), were
assessed using the Manual Tender Point Survey [23], and
responses were calculated by summing the patients'
responses to palpation of the 18 TPs.
Psychometric assessment
Three self-report measures that had been used in previous
studies of FMS (for example, [6,8,21]) were included. These
consisted of the following:
The Fibromyalgia Impact Questionnaire (FIQ) [24,25] is a 19-
item self-report questionnaire measuring physical impairment,
fatigue, stiffness, and functional activities, including sleep. The
FIQ has good psychometric properties (for example, [26]).
The West Haven-Yale Multidimensional Pain Inventory (MPI)
[27,28] is a 60-item questionnaire assessing pain intensity,
interference of pain, life control, affective distress, social sup-
port, significant-other responses, and general activity levels.
The MPI has been widely used with diverse chronic pain sam-
ples, including FMS [28-30], and has been demonstrated to
have good psychometric properties [28-30].
Cognitive variables were assessed using the 32-item Pain-
Related Self-Statements Scale (PRSS) [31] with the sub-
scales 'active coping' (for example, 'I can handle my pain') and
'catastrophising' (for example, 'I am a hopeless case') shown
to have excellent psychometric properties [31].
In addition to performing the measures enumerated above, all
patients completed treatment expectation ratings before the
first sessions and satisfaction ratings at the end of the first and
last sessions based on Borcovec and Nau [32]. Satisfaction
was rated on a 6-point scale ranging from 0 ('completely
unsatisfied') to 6 ('completely satisfied'). This measure was
included as a means of determining whether the groups dif-
fered in their beliefs about the quality of the treatment
received.
Assessment of pain behaviors
Pain behaviours were elicited by the standardised perform-
ance of a window washing task. Patients were videotaped per-
forming this task. Pain behaviours were assessed using the
Tübingen Pain Behaviour Scale (TBS) [33]. The frequency of
occurrence of each pain behaviour was coded by two inde-
pendent raters in 10-second epochs for a period of 8 minutes
[10]. The TBS rates the presence of behaviours on a 0–2
scale (0 = none, 1 = sometimes, 2 = always). The total value
of pain behaviours was calculated by summing the absolute
frequencies of the individual pain behaviours observed during
the task. The inter-rater reliability was good (kappa = 0.82; P
< 0.001). Scores for pain behaviours in the absence and in the
presence of the spouse were computed.
Health care utilisation
Medication consumption and number of physician visits 12
months prior to and 12 months after treatment were obtained
from the medical records maintained at the various Rheumatol-
ogy Outpatient Clinics. Patients were routinely observed at the
clinic at 6-week scheduled intervals.
Treatments
Each treatment consisted of 15 weekly 2-hour sessions co-led
by a psychologist and rheumatologist and conducted in
groups of five patients. Spouses attended the first, fifth, ninth,
and 13th sessions. Both CBT and OBT were based on struc-
tured manuals [34], whereas the AP treatment consisted of
unstructured discussions of problems associated with having
FMS and support provided by the therapists and group mem-
bers.
Cognitive behavior therapy
The CBT focused on the patients' thinking and involved prob-
lem-solving, stress and pain coping strategies, and relaxation
[34,35]. Patients were taught the meaning of the stress-ten-
sion-pain circle as a cognitive pain model and learned coping
strategies and the reduction of catastrophising thoughts.
Patients and spouses received weekly homework tasks, were
encouraged to engage in physical activities, and were asked
to reduce analgesic medication use at a gradual rate over the
course of the treatment. The patients participated in relaxation
exercises during and between the sessions. The therapists
identified instances of maladaptive thinking and encouraged
the group to challenge these instances and to provide more
appropriate interpretations and alternatives. Although the
importance of behaviour change was noted, the focus of this
treatment was on the change of maladaptive thoughts and atti-
tudes. The treatment was administered in the fashion of a
Socratic dialogue.Arthritis Research & Therapy    Vol 8 No 4    Thieme et al.
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Operant behavior therapy
The OBT was primarily based on changing observable pain
behaviours and included video feedback of expressions of
pain as well as contingent positive reinforcement of pain-
incompatible behaviours and punishment of pain behaviours in
a group setting. Structured time-contingent exercises were
provided according to operant principles [20] in the sessions
and as homework exercises. The treatment also included time-
contingent intake and reduction of medication, increase of
bodily activity, reduction of interference of pain with activities,
reduction of pain behaviours, and training in assertive pain-
incompatible behaviours [34]. Patients engaged in role-play-
ing to reduce pain behaviours and increase healthy behav-
iours. Patients, their spouses, as well as group members used
a reinforcer plan that consisted of the presentation of a 'red
card' when pain behaviours were displayed and a 'green card'
when healthy behaviours were displayed. Patients were
encouraged to increase their activity levels and were assigned
homework that included specific instructions to increase activ-
ities and reduce pain behaviours. A reduction of medication
was instituted immediately after the assessment phase, based
on a physician-coordinated individual time-contingent interval
plan. In contrast to CBT, this treatment focused primarily on
behavioural expressions of pain and emphasised changing
inappropriate pain behaviours without directly targeting mala-
daptive thoughts or cognitive aspects of coping.
Attention placebo
The AP treatment focused on general discussions among
patients in groups guided by therapists. The discussions were
centered around medical and psychosocial problems of FMS
(that is, stress in different areas of the patients' lives, physi-
cian-patient interaction, and use of medication). Within the
groups, patients were provided with opportunities to speak
about problems with coping, fatigue, pain, stress, and medica-
tion. The therapists did not initiate these topics and made no
specific recommendations. The patients did not receive any
specific homework.
Treatment adherence
Adherence to the treatment was assessed by the number of
sessions attended and the completion of homework assign-
ments in CBT and OBT (Table 1).
Therapists
Three psychologists, each with more than 15 years of experi-
ence of treatment, conducted the groups. They completed a 2-
day training program together with 10 rheumatologists who
served as co-therapists. Additionally, psychologists and rheu-
matologists met to decide which study information the patients
should receive from the physician and to outline strategies for
difficult situations, including problems with motivation and
non-adherence.
Statistical analyses
The intent-to-treat principle guided the analyses such that the
baseline scores (that is, 'last' observation) for those who termi-
nated treatment prematurely were carried forward. The primary
outcome measures were changes in pain intensity, physical
functioning, affective distress, and health care utilisation
[23,36] at post-treatment and the 6- and 12-month follow-ups.
The initial analyses of treatment effectiveness were assessed
using a multivariate analysis of variance (MANOVA) for pain,
function, and mood. Significant main effects and interactions
were followed by post hoc analysis of variance (ANOVA) and
t tests.
Figure 1
CONSORT (Consolidated Standards for Reporting of Trials) diagram CONSORT (Consolidated Standards for Reporting of Trials) diagram. AP, attention-placebo; CBT, cognitive behavioural therapy; OBT, operant 
behavioral therapy; Tx, treatment.Available online http://arthritis-research.com/content/8/4/R121
Page 5 of 12
(page number not for citation purposes)
The emphasis of CBT was on changing beliefs and expectan-
cies, whereas the OBT was designed to change pain behav-
iours. To confirm the validity of the treatments, a series of 2 ×
2 MANOVAs was performed. Significant effects were fol-
lowed up with univariate ANOVAs and t tests. The outcome
MANOVA included three variables and used a P value Bonfer-
roni-adjusted to P < 0.02. The MANOVA on cognitive and
behavioural effects included two variables and used a Bonfer-
roni-adjusted P < 0.03.
To determine whether the treatment effects were clinically sig-
nificant, the effect sizes (ESs) for the combined OBT and CBT
groups and the individual responses for the OBT and CBT
groups were compared with the AP group and computed
based on the formula: AP (meanT2–4) – CBT [or OBT]
(meanT2–4)/CBT/[or OBT] (standard deviationT1) [37]. To
avoid overestimation of the CBT and OBT related to the dete-
rioration of the AP group which became apparent during data
analysis, ESs were compared for the entire AP group and the
subgroup of AP patients who dropped out and whose values
were carried forward. This procedure compared the ESs of the
OBT and CBT groups with a no-change subgroup of the AP
group. The comparison of CBT and OBT with the AP group
may have been distorted by the large number of dropouts in
the AP group and the deterioration in many variables in the
patients who remained in the group. Therefore, we computed
an adjusted ES that included the baseline values of the drop-
outs of the AP group which were carried forward for the post-
treatment analyses at the 12-month follow-up.
Results
Attrition
Three patients in the OBT (6.9%), two in the CBT (4.8%), and
20 in the AP (50%) groups terminated the treatment prema-
turely (Figure 1). All dropouts occurred between sessions 1
and 4. The primary reason that patients gave for dropping out
of the AP group was deterioration of symptoms. Patients who
terminated prematurely were not significantly different from
those who completed treatment in duration of symptoms, ini-
tial pain severity, or number or severity of TPs. Overall, 100
patients completed the treatments, 40 in the OBT group, 40
in the CBT group, and 20 in the AP group.
Treatment expectation and satisfaction
There were no statistically significant differences between the
groups in treatment expectations (F(2, 122) = 1.47, P = 0.24)
in the first treatment session. For treatment satisfaction, calcu-
lated as a combination of first and last session, an ANOVA
revealed neither a significant group (F(2, 122) = 1.42, P =
0.25) nor a significant group × phase (first versus last session)
(F(2, 122) = 0.53, P = 0.59) effect.
The adherence of patients in the CBT and OBT groups was
excellent. In the OBT group, only 4.3% sessions were missed
and 5.5% of homework was not completed. In the CBT group,
3.2% sessions were missed and 4.7% of homework was not
completed. The subsample of the AP group who were retained
in the treatment missed 7.6% sessions.
Primary outcomes
Physical impairment was assessed by the FIQ, and pain inten-
sity and affective distress were assessed by the MPI. Number
of physician visits was used as behavioural variable [35,36].
The MANOVA revealed a significant effect of both group (F(2,
122) = 15.63, P < 0.001) and outcome (F(3, 120) = 82.53, P
< 0.001) variables. There was no significant effect of time but
significant time × group (F(2, 122) = 15.92, P < 0.001), out-
come variables × time (F(3, 120) = 4.79, P < 0.005), and
group × time × outcome variables (F(3, 121) = 12.53, P <
0.001) interactions. The post hoc ANOVA revealed a signifi-
cant difference between CBT and AP (P  < 0.001) and
between OBT and AP (P < 0.001) but not between CBT and
OBT (P = 1.00).
Physical impairment
The post hoc ANOVA revealed a statistically significant group
× time interaction (Table 2) with OPT and CBT significantly
different from AP but not from one another. Interestingly, OBT
and CBT showed a statistically significant decrease of func-
tional limitations at the 12-month follow-up, whereas the AP
group displayed a statistically significant increase at the 12-
month follow-up (Figure 2). However, only the OBT showed
significantly reduced functional limitations 12 months after the
treatment compared with pre-treatment (Table 2) whereas
their functional limitations did not change immediately after or
6 months after treatment. Functional limitations showed a
large ES (Table 3) for the OBT (1.15) which increased from
pre-treatment to the two follow-up periods.
Pain intensity
The ANOVA on pain intensity revealed a significant group ×
time interaction (F(3, 121) = 11.95, P < 0.001) with signifi-
cant differences between AP and both CBT and OBT. Both
CBT and OBT showed significant pain reduction (Table 2) at
the 6-month and 12-month follow-ups. Unexpectedly, the AP
group showed a statistically significant increase of pain inten-
sity 6 months after the treatment in comparison with the CBT
and OBT. There were no significant differences between CBT
and OBT at the 6-month and 12-month follow-ups (Figure 3).
Comparable with physical impairment, pain intensity did not
change immediately after or 6 months after treatment (Table
2). There were large ESs for pain intensity (Table 3) in both the
CBT (1.14) and the OBT treatments (1.10). In general, the
ESs of the CBT and OBT increased over time, supporting the
maintenance of the improvements.
Affective distress
Consistent with the results for pain and functional impact, the
ANOVA yielded a significant group × time interaction (F(3,Arthritis Research & Therapy    Vol 8 No 4    Thieme et al.
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Table 2
Means, SDs, and F and P values for ANOVA effects for group, time, and group × time (G × T) and T and P values for the main 
outcome variables
Outcome variables
Main effects
Outcome 
variables
Group Pre-treatment 
Mean (SD)
Post-
treatment 
Mean (SD)
6-month f/u 
Mean (SD)
12-month f/u 
Mean (SD)
Group
F
P
Time
F
P
G × T
F
P
T1 vs. T2
T
P
T1 vs. T3
T
P
T1 vs. T4
T
P
FIQ – Physical 
impairment
CBT 4.35 (2.12) 3.64 (2.30) 3.00 (2.43) 3.42 (2.29) 2.45 ns 0.71 ns 0.84 ns
OBT 4.77 (2.24) 4.50 (1.91) 3.94 (2.06) 2.63 (1.57) 0.10 ns 0.63 ns 3.13 0.004
AP 4.19 (2.08) 4.03 (2.09) 4.77 (2.60) 5.20 (2.51) 0.17 ns -2.27 ns -2.90 0.006
CBT vs. OBT (F, P) 1.28 ns 5.02 ns 1.73 ns 1.94 ns 3.07 ns 0.68 ns 6.57 0.001
CBT vs. AP (F, P) 0.01 ns 1.28 ns 4.79 ns 6.36 0.010
OBT vs. AP (F, P) 1.06 ns 0.76 ns 1.35 ns 16.38 <0.001
Pain intensity CBT 4.15 (0.84) 3.54 (1.03) 3.73 (0.94) 3.18 (1.42) 3.45 0.002 3.14 0.003 4.32 0.001
OBT 4.22 (0.99) 4.12 (1.12) 3.77 (0.94) 3.05 (1.40) 0.56 ns 3.29 0.002 4.64 <0.001
AP 3.80 (0.99) 3.79 (1.07) 4.07 (1.07) 4.14 (1.46) 0.39 ns -2.82 0.008 -2.08 ns
CBT vs. OBT (F, P) 0.21 ns 2.23 ns 0.15 ns 0.49 ns 1.83 ns 11.70 <0.001 11.95 <0.001
CBT vs. AP (F, P) 2.72 ns 1.04 ns 2.94 ns 8.77 0.004
OBT vs. AP (F, P) 2.74 ns 1.69 ns 1.82 ns 11.79 0.001
MPI – Affective 
distress
CBT 3.22 (1.02) 2.84 (1.10) 2.57 (1.05) 2.56 (1.24) 2.02 ns
OBT 3.17 (1.44) 3.31 (1.29) 3.14 (1.23) 2.92 (1.23) -0.61 ns
AP 3.54 (1.29) 3.62 (1.34) 3.99 (1.37) 4.16 (1.44) -0.90 ns
CBT vs. OBT (F, P) 0.29 ns 2.43 ns 2.88 ns 1.09 ns 8.34 0.001 0.28 ns 5.89 <0.001
CBT vs. AP (F, P) 1.96 ns 6.97 ns 20.65 <0.001 27.83 <0.001
OBT vs. AP (F, P) 2.79 ns 0.96 ns 4.94 ns 9.26 0.004
Number of 
physician visits
CBT 30.55 (16.20) 25.27 (18.47) 1.79 ns
OBT 36.87 (15.15) 16.35 (18.26) 5.57 <0.001
AP 34.13 (12.17) 47.65 (20.01) -5.56 <0.001
CBT vs. OBT (F, P) 2.59 ns 4.77 0.010 10.99 <0.001 5.59 0.020 33.52 <0.001
CBT vs. AP (F, P) 1.16 ns 24.22 <0.001
OBT vs. AP (F, P) 0.72 ns 46.04 <0.001
Comparisons refer to pre-treatment, post-treatment, and 6- and 12-month follow-ups in the CBT, OBT, and AP groups. ANOVA, analysis of 
variance; AP, attention-placebo; CBT, cognitive behavior therapy; FIQ, Fibromyalgia Impact Questionnaire; f/u, follow-up; MPI, Multidimensional Pain 
Inventory; ns, not significant; OBT, operant behaviour therapy; SD, standard deviation.Available online http://arthritis-research.com/content/8/4/R121
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121) = 5.89, P < 0.005) with significant group differences
between CBT and AP and between OBT and AP but not
between CBT and OBT (Table 2). The CBT showed a signifi-
cant decrease of affective distress (Table 2) immediately after,
6 months after, and 12 months after treatment. The OBT did
not display any significant changes over time (Table 2). In con-
trast to CBT and OBT (Table 2), the AP group showed an
increase of affective distress at 6 months after treatment and
a further increase 12 months after treatment.
In comparison with AP, the CBT patients achieved significantly
lower levels of affective distress immediately after, 6 months
after, and 12 months after treatment, the OBT patients only
after 12 months. There were no significant differences
between CBT and OBT (Figure 4). The CBT demonstrated
large effects in reducing affective distress (0.76–1.57) with
increasing ESs over time (Table 3).
Physician visits
An ANOVA demonstrated a significant group × time interac-
tion (F(2, 122) = 33.52, P < 0.001) with significant group dif-
ferences between OBT and AP (P < 0.001) and between
CBT and AP (P = 0.001) but not between CBT and OBT (P
= 0.48). The CBT did not show any significant changes over
time (Table 2). The OBT displayed a significant decrease of
physician visits (Table 2) at the 12-month follow-up, whereas
the AP group showed a significant increase of the numbers of
physician visits at the 12-month follow-up.
In comparison with AP patients, CBT- and OBT-treated
patients had made significantly fewer physician visits at the
12-month follow-up. There were, however, no significant differ-
ences between CBT and OBT. The number of physician visits
showed a very large ES for the OBT with 2.13 (1.45 adjusted).
Targeted treatment effects
Cognitive variables
The CBT treatment was specifically designed to target mala-
daptive beliefs. To confirm the efficacy of the treatment on
cognitive variables, a MANOVA on the two scales of the
PRSS, active coping and catastrophising, was calculated. It
revealed a significant effect of time (F(1, 122) = 4.52, P <
0.03), cognitive variables (F(1, 122) = 5352, P < 0.001), cog-
nitive variables × time (F(1, 122) = 8.32, P < 0.01), cognitive
variables × group (F(2, 122) = 14.92, P < 0.001), and cogni-
tive variables × time × group (F(2, 122) = 27.41, P < 0.001).
There was no significant effect of treatment (F(1, 122) = 0.77,
P = 0.47).
Coping
An ANOVA demonstrated a significant interaction for group ×
time (F(3, 121) = 16.18, P < 0.001) with significant group dif-
ferences between CBT and AP and between OBT and AP but
not between CBT and OBT. Both CBT and OBT showed a
significant increase of adaptive coping (Table 4) immediately
after the treatment as well as at the 6-month and 12-month fol-
low-ups. In contrast to CBT and OBT (Table 4), the AP group
showed a decline in the use of positive coping at both follow-
ups.
In comparison with the AP, the CBT-treated patients
responded with improved coping immediately after, 6 months
after, and 12 months after the treatment, OBT-treated patients
only after 6 and 12 months. There were no significant differ-
ences between CBT and OBT. CBT produced a larger ES
(2.66) on active coping than did the OBT treatment (1.23),
although both were large. In general, the ESs of the CBT and
OBT increased over time (Table 3).
Catastrophising
Post hoc ANOVAs demonstrated a significant treatment ×
time interaction (F(3, 121) = 12.99, P < 0.001) with signifi-
cant group differences between CBT and AP (P < 0.03) and
between OBT and AP (P < 0.005) but not between CBT and
OBT. The CBT and OBT showed a significant decrease of cat-
astrophising (Table 4) immediately after treatment as well as at
the 6- and 12-month follow-ups. In contrast to the CBT and
OBT (Table 4), the AP group showed an increase of catastro-
phising at the follow-ups.
The CBT and OBT groups showed significantly less catastro-
phising immediately after treatment, and this was maintained
over both follow-ups in comparison with the AP group. Larger
ESs for catastrophising were obtained for CBT (1.44) than for
OBT (0.97), although both ESs were large (Table 3).
Behavioural variables
These included pain behaviours and pain-related solicitous
spouse behaviours. A MANOVA revealed a significant effect
for group (F(2, 122) = 3.36, P < 0.03), variables (F(2, 121) =
126.35, P < 0.001), variables × group (F(2, 121) = 9.12, P <
0.001), time × group (F(2, 122) = 16.39, P < 0.001), and
group × time × variables (F(2, 122) = 30.09, P < 0.001). Post
hoc analyses showed a significant difference between OBT
and AP (P < 0.02) but not between CBT and AP or between
CBT and OBT.
Pain behaviors
Post hoc ANOVAs demonstrated a significant treatment ×
time (F(3, 121) = 11.39, P < 0.001) effect with significant
group differences only between OBT and AP (P < 0.02) but
not between CBT and AP or between CBT and OBT (Table
4). Whereas the CBT did not show any significant decrease of
pain behaviour (Table 4), the OBT displayed a significant
decrease of pain behaviour (Table 4) immediately after the
treatment and at the 6-month and 12-month follow-ups. In con-
trast to CBT and OBT (Table 4), the AP group showed a sig-
nificant increase in pain behaviours immediately after and at
the 6- and 12-month follow-ups.Arthritis Research & Therapy    Vol 8 No 4    Thieme et al.
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OBT patients reduced their pain behaviours immediately after
the treatment, an effect that was maintained for a period of at
least 12 months. CBT patients showed a significant reduction
in pain behaviours only 12 months after treatment. Overall,
observed pain behaviours showed a very large ES (Table 3) for
OBT (1.59) in contrast to a moderate ES for CBT (0.57).
Significant-other behaviours
The ANOVA revealed a significant group × time interaction
(F(3, 121) = 7.65, P < 0.001) with significant group differ-
ences between OBT and AP (P < 0.02) but not between CBT
and AP or between CBT and OBT. The OBT displayed a sta-
tistically significant decrease of solicitous spouse behaviour
immediately after the treatment as well as at the two follow-
ups. The AP group showed a statistically significant increase
of solicitous behaviour at the follow-ups. The CBT did not
show any significant changes over time (Table 4). The CBT
patients showed lower solicitous spouse behaviour immedi-
ately after the treatment in comparison with the AP patients.
However, this effect was not maintained. The OBT group
showed fewer solicitous spouse behaviours than the AP
patients at the 12-month follow-up. There were no significant
differences between CBT and OBT. Only the OBT experi-
enced a significant reduction of solicitous significant-other
behaviours over time. The ES for reduced solicitous spouse
behaviour (Table 3) after OBT increased over the time.
Adjusted ESs
The adjusted ESs were still moderate to high but substantially
lower than the uncorrected ESs (Table 3). The OBT showed
greater effects in the reduction of physical impairment (ES =
1.07) and pain behaviour (ES = 1.48), whereas the CBT
showed the greatest increase in coping (ES = 1.70) and
reduction in affective distress (ES = 0.61).
Discussion
Both the CBT and OBT groups reported significant improve-
ments in physical functioning, pain, and emotional distress 1
year after treatment, in comparison with the AP group. The lat-
ter actually demonstrated significant deterioration after treat-
ment. Even though no statistically significant differences were
identified favoring CBT or OBT overall, the within-calculations
for each group over time revealed that the CBT did not dem-
onstrate as pronounced a set of treatment effects in functional
Figure 2
Differences in physical impairment among cognitive behavioural ther- apy (CBT) (solid line), operant behavioral therapy (OBT) (dashed line),  and attention-placebo (AP) (dotted line) groups prior to treatment (T1),  immediately after treatment (T2), and at 6- (T3) and 12-month (T4) fol- low-ups Differences in physical impairment among cognitive behavioural ther-
apy (CBT) (solid line), operant behavioral therapy (OBT) (dashed line), 
and attention-placebo (AP) (dotted line) groups prior to treatment (T1), 
immediately after treatment (T2), and at 6- (T3) and 12-month (T4) fol-
low-ups.
Figure 3
Differences in pain intensity among cognitive behavioural therapy  (CBT) (solid line), operant behavioral therapy (OBT) (dashed line), and  attention-placebo (AP) (dotted line) groups prior to treatment (T1),  immediately after treatment (T2), and at 6- (T3) and 12-month (T4) fol- low-ups Differences in pain intensity among cognitive behavioural therapy 
(CBT) (solid line), operant behavioral therapy (OBT) (dashed line), and 
attention-placebo (AP) (dotted line) groups prior to treatment (T1), 
immediately after treatment (T2), and at 6- (T3) and 12-month (T4) fol-
low-ups.
Figure 4
Differences in affective distress among cognitive behavioural therapy  (solid line), operant behavioral therapy (dashed line), and attention-pla- cebo (dotted line) groups prior to treatment (T1), immediately after  treatment (T2), and at 6- (T3) and 12-month (T4) follow-ups Differences in affective distress among cognitive behavioural therapy 
(solid line), operant behavioral therapy (dashed line), and attention-pla-
cebo (dotted line) groups prior to treatment (T1), immediately after 
treatment (T2), and at 6- (T3) and 12-month (T4) follow-ups.Available online http://arthritis-research.com/content/8/4/R121
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limitations, whereas the OBT revealed somewhat less of a
treatment effect in affective distress.
A clear superiority was found for the active psychological inter-
ventions in comparison with the AP group. In fact, the results
were increased at the 6-month and 12-month follow-ups, and
notably, the demonstrated beneficial effects were achieved
without the inclusion of an additional structured physical ther-
apy program or additional antidepressant medication. These
results have important implications because physical therapy
and antidepressant medication are often recommended as
important components of treatment for FMS [18]. Future stud-
ies should directly compare these very different treatment
approaches and also perform responder analyses to clarify the
characteristics of patients who require different treatments to
achieve beneficial effects.
Interestingly, no significant differences on the cognitive varia-
bles were observed between the CBT and OBT groups. One
explanation that seems plausible is that, although the CBT
treatment directly focused on cognitive variables, it is possible
that the behavioural changes and symptom improvements
achieved by the patients treated by OBT produced changes in
active coping and catastrophising without targeting those
directly. Thus, observation of one's behaviour and experiences
of increased activities may produce changes in a patient's
beliefs about their plight.
The most significant changes for CBT were found with respect
to pain and cognitive and affective variables. Positive cogni-
tions were successively increased, and patients learned to
improve their use of coping strategies to decrease cata-
strophic thinking with the consequence of reduced affective
distress. These results are consistent with previous research
[15,16] and indicate that the treatment successfully targeted
improvements in cognitive coping. These results were stable
over 12 months and clinically significant. Despite the fact that
the CBT treatment did not directly focus on pain behaviours,
the present results support a moderate benefit of the treat-
ment on behaviours (ES = 0.57, 0.49 adjusted). Apparently,
changing patients' beliefs is a critical aspect of treatment,
regardless of whether they are directly targeted or derived
from the observation of the patients' own behaviour [38].
Significant changes for OBT were found with respect to pain
and physical and behavioural variables. In accordance with
previous reports [14,21], healthy behaviours were succes-
sively increased and pain behaviours were decreased. The
OBT, notably, achieved statistically significant reductions in
physician visits (50%) in direct contrast to the AP group,
which almost doubled the number of visits. CBT, however,
produced only a modest and not statistically significant reduc-
tion of physician consultations. These results suggest that the
OBT treatment may not only provide clinical benefits but also
produce significant reductions in health care utilisation.
As hypothesised, the analysis of clinical significance demon-
strated that CBT had a relatively greater effect in the reduction
of affective distress and catastrophising, whereas OBT had a
relatively greater effect in the reduction in functional limita-
tions, pain behaviours, and solicitous spouse behaviour. These
data support the validity of the treatments. Regarding pain
intensity and coping, CBT and OBT showed similar effects.
CBT focused on changes of cognitions with the effect of
reduced cognitive factors of pain, whereas OBT focused on
behavioural changes and reached reductions of physical and
operant components of pain. Although it is not surprising that
CBT and OBT reached comparable effects in pain reduction,
Table 3
Effect sizes of the dependent variables in the CBT and OBT groups in comparison with the AP group at pre-treatment (T1), post-
treatment (T2), and 6 months (T3) and 12 months (T4) after treatment
Group
CBT – AP OBT – AP
Variable ES T1–T2 ES T1–T3 ES T1–T4 ES T1–T4a ES T1–T2 ES T1–T3 ES T1–T4 ES T1–T4a
FIQ – Physical impairment 0.18 0.83 0.84 0.71 0.21 0.37 1.15 1.07
MPI – Pain 0.29 0.40 1.14 0.31 0.33 0.30 1.10 0.62
MPI – Affective distress 0.76 1.39 1.57 0.61 0.22 0.59 0.86 0.72
PRSS – Coping 1.16 1.72 2.66 1.70 0.21 0.73 1.23 0.38
PRSS – Catastrophising 0.62 0.96 1.44 0.54 0.12 0.89 0.97 0.41
Pain behaviour 0.44 0.42 0.57 0.49 0.59 0.72 1.89 1.48
MPI – Solicitous spouse 
behaviour
0.19 0.41 0.44 0.37 0.43 1.00 1.71 0.57
aAdjusted ES based on the AP group with the dropout values from baseline carried forward to the 12-month follow-up. Medium (>0.5) and large 
(>0.8) ESs were bolded. AP, attention-placebo; CBT, cognitive behaviour therapy; ES, effect size; FIQ, Fibromyalgia Impact Questionnaire, MPI, 
Multidimensional Pain Inventory; OBT, operant behavior therapy; PRSS, Pain Related Self-Statements Scale.Arthritis Research & Therapy    Vol 8 No 4    Thieme et al.
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Table 4
Means, SDs, and F and P values of the ANOVA effects for group, time, and group × time (G × T) and T and P values for secondary 
measures: cognitive variables and behavioural variables pre-treatment (T1) in comparison with post-treatment (T2), 6 months (T3) 
and 12 months (T4) in the CBT, OBT, and AP groups
Secondary variables – Cognitive variables
Main effects
Secondary 
variables
Group T1 Mean 
(SD)
T2 Mean 
(SD)
T3 Mean (SD) T4 Mean (SD) Group
F
P
Time
F
P
G × T
F
P
T1 vs. T2
T
P
T1 vs. T3
T
P
T1 vs. T4
T
P
PRSS – Coping CBT 3.25 (0.61) 3.68 (0.76) 3.74 (0.59) 3.89 (0.54) -3.29 0.002 -3.28 0.002 -4.83 <0.001
OBT 2.96 (1.02) 3.18 (0.99) 3.43 (0.80) 3.52 (1.10) -1.82 ns -3.43 0.002 -2.72 0.010
AP 2.94 (0.68) 2.97 (0.99) 2.69 (0.72) 2.27 (0.99) -0.37 ns 2.94 0.006 4.66 <0.001
CBT vs. OBT (F, P) 2.20 ns 5.90 0.02 3.29 ns 3.05 ns 20.44 <0.001 5.16 0.002 16.18 <0.001
CBT vs. AP (F, P) 3.34 ns 18.01 ns 46.19 <0.001 74.50 <0.001
OBT vs. AP (F, P) 0.01 ns 1.15 ns 17.28 <0.001 26.42 <0.001
PRSS – 
Catastrophising
CBT 2.29 (0.93) 1.69 (1.04) 1.69 (1.08) 1.49 (1.06) 4.14 <0.001 3.55 0.001 4.12 <0.001
OBT 2.48 (1.20) 2.13 (1.31) 1.67 (1.01) 1.67 (1.21) 2.48 0.018 4.65 <0.001 4.23 <0.001
AP 2.36 (1.02) 2.27 (1.00) 2.58 (0.93) 2.83 (1.13) 1.05 ns -2.37 0.023 -2.94 0.006
CBT vs. OBT (F, P) 0.54 ns 2.50 0.020 0.04 ns 0.44 ns 6.52 0.002 8.76 <0.001 12.99 <0.001
CBT vs. AP (F, P) 0.10 ns 6.27 0.014 14.91 <0.001 27.54 <0.001
OBT vs. AP (F, P) 0.19 ns 0.29 ns 16.25 <0.001 17.86 <0.001
Secondary variables – Behavioural variables
Pain behaviour CBT 89.91 
(73.40)
72.10 
(56.63)
80.11 (65.79) 82.84 (73.32) 1.88 ns 0.97 ns 0.73 Ns
OBT 114.16 
(51.32)
73.96 
(40.71)
64.89 (43.20) 42.63 (49.35) 2.67 0.011 3.03 0.005 3.43 0.001
AP 88.79 
(49.13)
104.38 
(49.81)
111.1 (52.66) 124.4 (57.17) -0.35 0.002 -3.39 0.002 -4.41 <0.001
CBT vs. OBT (F, P) 1.10 ns 0.03 0.02 1.23 ns 6.86 0.010 2.68 ns 2.37 ns 11.39 <0.001
CBT vs. AP (F p) 0.01 ns 5.49 0.02 4.01 ns 5.94 0.020
OBT vs. AP (F, P) 1.13 ns 7.01 0.01 13.73 <0.001 34.77 <0.001
MPI – Solicitous 
spouse 
behaviour
CBT 3.30 (1.62) 2.97 (1.25) 3.32 (1.31) 3.39 (1.10) 0.68 ns 0.02 ns -0.14 Ns
OBT 4.00 (0.79) 2.95 (1.02) 3.20 (1.44) 2.76 (1.31) 4.33 <0.001 3.37 0.020 4.16 0.001
AP 3.23 (1.25) 3.29 (1.21) 3.99 (1.17) 4.11 (1.16) -0.68 ns -2.91 0.006 -3.16 0.003
CBT vs. OBT (F, P) 2.43 ns 0.01 ns 0.02 ns 2.22 ns 1.18 ns 4.07 0.011 6.58 0.001
CBT vs. AP (F, P) 0.01 ns 1.33 0.014 3.73 ns 3.25 ns
OBT vs. AP (F, P) 3.07 ns 2.04 ns 4.34 ns 11.35 0.001Available online http://arthritis-research.com/content/8/4/R121
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the focus of treatment used to accomplish these outcomes
varied substantially. Taken together, these data suggest that
CBT might be especially beneficial in patients with high levels
of cognitive maladaptation to the pain and high affective dis-
tress, whereas OBT might be especially efficacious in patients
with high levels of pain behaviours and low physical function-
ing. Future research will have to determine to what extent this
is true or whether it might be beneficial to combine elements
of both treatments.
Unexpectedly, the AP group significantly deteriorated during
the study, with a worsening of symptoms on all outcome meas-
ures, which may explain the large proportion (50%) of AP
patients' terminating treatment prematurely. Unstructured dis-
cussion about problems aligned with coping with chronic pain
appeared to lead to increased pain, functional limitations, emo-
tional distress, and pain behaviours. This might be due to the
disease-oriented, solicitous behaviour of group members
which may have reinforced pain and pain behaviour. The dete-
rioration of the AP was not limited to the pre-post comparison
but persisted up to 12 months after treatment termination.
One possible explanation for the large dropout in the AP group
might be that the treatment was simply not credible or was
viewed as unsatisfactory. This explanation was not supported
by the results on patient satisfaction. There were no significant
differences in patient satisfaction among the three groups. The
long-lasting deterioration of the AP group was unexpected and
needs to be explored. If confirmed, these results suggest that,
at least for a subset of patients, discussions about pain and
possibly informal support groups may be detrimental.
There are several limitations in this study, and the large number
of dropouts in the AP group is disconcerting indeed. The unex-
pected detrimental effects of the AP group are a significant
concern and may have contributed to the large ESs reported.
Because this result may have overestimated the true effects of
the behavioural treatments, we also computed ESs for the car-
ried-forward baseline data of the dropouts. The ESs that were
obtained are still moderate to large, suggesting a substantial
effect of the behavioural treatments.
The interpretation of the results of the ANOVAs on the sub-
groups must be considered with caution due to the small sam-
ple sizes. Larger studies are needed to replicate the results. All
participants in this study had to have a spouse who was willing
to participate. Turk et al. [13] reported that almost 40% of
patients with FMS indicated high levels of interpersonal dis-
tress. The generalisability of the results of this study to unmar-
ried FMS patients and patients with poor interpersonal
relations also needs to be confirmed.
Conclusion
Despite the limitations noted, it appears that psychologically
based treatments are capable of producing both statistically
significant and clinically meaningful benefits for patients with
long-standing FMS, without the specific inclusion of a struc-
tured physical therapy plan or antidepressant medications.
Importantly, the results demonstrated that the changes were
maintained up to 12 months after treatment. Moreover, there
were significant reductions in physician visits, primarily for the
OBT treatment, that would result in substantial cost savings in
response to FMS therapy. Although promising, these treat-
ments are geared toward FMS symptoms such as pain, phys-
ical impairment, and affective distress but probably do not
address causal factors of the disorder, which are still
unknown.
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